Skip to main content
SpringerLink
Log in

Concomitant drug, dietary, and lifestyle issues in patients with atrial fibrillation receiving anticoagulation therapy for stroke prophylaxis

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Atrial fibrillation is a common cardiac arrhythmia and the leading risk factor for stroke. In those at moderate to high risk of stroke, oral anticoagulation therapy with warfarin (a vitamin K antagonist) significantly reduces not only the frequency of such events but also their severity and the associated risk of death. However, achieving optimal anticoagulation with this agent is clinically challenging in view of its complex pharmacokinetic and pharmacodynamic profile. In this regard, concomitant drug therapy (both prescription and over-the-counter medications, including herbal products, vitamins, and various nutritional supplements), along with alcohol intake, dietary factors, and changes in lifestyle, can significantly affect anticoagulation control and thereby expose patients to the risk of bleeding or thromboembolic complications (due to over- and underanticoagulation, respectively). Therefore, it is recommended that intensified monitoring of anticoagulation be performed at initiation and discontinuation of concomitant drug therapy, and in the case of significant dietary and lifestyle changes. Moreover, many patients receive inadequate education and are unaware of such risks and their implications, highlighting the need for better awareness and education on this important aspect of anticoagulation therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Booth SL, Centurelli MA: Vitamin K: A practical guide to the dietary management of patients on warfarin. Nutr Rev 1999, 57:288–296.

    Article  PubMed  CAS  Google Scholar 

  2. Singer DE: Anticoagulation to prevent stroke in atrial fibrillation and its implications for managed care. Am J Cardiol 1998, 81:35C-40C.

    Article  PubMed  CAS  Google Scholar 

  3. Petersen P, Boysen G, Godtfredsen J, et al.: Placebo controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989, 1:175–179.

    Article  PubMed  CAS  Google Scholar 

  4. The effect of low dose warfarin on the risk of stroke in patients with non rheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators [no authors listed]. N Engl J Med 1990, 323:1505–1511.

  5. Connolly SJ, Laupacis A, Gent M, et al.: Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991, 18:349–355.

    Article  PubMed  CAS  Google Scholar 

  6. Stroke Prevention in Atrial Fibrillation Study. Final results [no authors listed]. Circulation 1991, 84:527–539.

  7. Ezekowitz MD, Bridgers SL, James KE, et al.: Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992, 327:1406–1412.

    Article  PubMed  CAS  Google Scholar 

  8. Secondary prevention in non rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group [no authors listed]. Lancet 1993, 342:1255–1262.

  9. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999, 131:492–501.

    PubMed  CAS  Google Scholar 

  10. van Walraven C, Hart RG, Singer DE, et al.: Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation. An individual patient meta-analysis. JAMA 2002, 288:2441–2448.

    Article  PubMed  Google Scholar 

  11. Fuster V, Ryden LE, Asinger RW, et al.: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001, 104:2118–2150.

    PubMed  CAS  Google Scholar 

  12. Hirsh J, Fuster V, Ansell J, Halperin JL, et al.: American Heart Association/American College of Cardiology foundation guide to warfarin therapy. J Am Coll Cardiol 2003, 41:1633–1652. Detailed and “handy” Practice Guideline focusing on the clinical applications and appropriate management of oral anticoagulation therapy.

    Article  PubMed  CAS  Google Scholar 

  13. Singer DE, Albers GW, Dalen JE, et al.: Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126(3 suppl):429S-456S. The most recent Consensus Conference of the American College of Chest Physicians provides guidelines for risk stratification and appropriate antithrombotic agent selection in patients with AF.

    Article  PubMed  CAS  Google Scholar 

  14. Ansell J, Hirsh J, Dalen J, et al.: Managing oral anticoagulant therapy. Chest 2001, 119(suppl):22S-38S.

    Article  PubMed  CAS  Google Scholar 

  15. Gage BF, Fihn SD, White RH: Management and dosing of warfarin therapy. Am J Med 2000, 109:481–488.

    Article  PubMed  CAS  Google Scholar 

  16. Hylek EM, Skates SJ, Sheehan MA, Singer DE: An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996, 335:540–546.

    Article  PubMed  CAS  Google Scholar 

  17. Hylek EM, Go AS, Chang Y, et al.: Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003, 349:1019–1026.

    Article  PubMed  CAS  Google Scholar 

  18. Barcellona D, Contu P, Sorano GG, et al.: The management of oral anticoagulant therapy: the patient’s point of view. Thromb Haemost 2000, 83:49–53.

    PubMed  CAS  Google Scholar 

  19. Tang EO, Lai CS, Lee KK, et al.: Relationship between patients’ warfarin knowledge and anticoagulation control. Ann Pharmacother 2003, 37:34–39.

    Article  PubMed  Google Scholar 

  20. Franco V, Polanczyk CA, Clausell N, Rohde LE: Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med 2004, 116:651–656.

    Article  PubMed  CAS  Google Scholar 

  21. Pedersen FM, Hamberg O, Hess K, Ovesen L: The effect of dietary vitamin K on warfarin induced anticoagulation. J Intern Med 1991, 229:517–520.

    Article  PubMed  CAS  Google Scholar 

  22. Booth SL, Charnley JM, Sadowski JA, et al.: Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content. Thromb Haemost 1997, 77:504–509.

    PubMed  CAS  Google Scholar 

  23. Landau J, Moulda RF: Warfarin resistance caused by vitamin K in intestinal feeds. Med J Aust 1982, 2:263–264.

    PubMed  CAS  Google Scholar 

  24. Parr MD, Record KE, Griffith GL, et al.: Effect of enteral nutrition on warfarin therapy. Clin Pharm 1982, 1:274–276.

    PubMed  CAS  Google Scholar 

  25. Weathermon R, Crabb DW: Alcohol and medication errors. Alcohol Res Health 1999, 23:40–54.

    PubMed  CAS  Google Scholar 

  26. Ha CE, Petersen CE, Park DS, et al.: Investigations of the effects of ethanol on warfarin binding to human serum albumin. J Biomed Sci 2000, 7:114–121.

    Article  PubMed  CAS  Google Scholar 

  27. Penning van Beest FJA, Geleijnse JM, van Meegen E, et al.: Lifestyle and diet as risk factors for overanticoagulation. J Clin Epidemiol 2002, 55:411–417.

    Article  Google Scholar 

  28. Kuykendall JR, Houle MD, Rhodes RS: Possible warfarin failure due to interaction with smokeless tobacco. Ann Pharmacother 2004, 38:595–597.

    Article  PubMed  Google Scholar 

  29. Cropp JS, Bussey HI: A review of enzyme induction of warfarin metabolism with recommendations for patient management. Pharmacotherapy 1997, 17:917–928.

    PubMed  CAS  Google Scholar 

  30. Wells PS, Holbrook AM, Crowther NR, Hirsh J: Interactions of warfarin with drugs and food. Ann Intern Med 1994, 121:676–683.

    PubMed  CAS  Google Scholar 

  31. Breckenridge A, Orme M, Wesseling H, et al.: Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man. Clin Pharmacol Ther 1974, 15:424–430.

    PubMed  CAS  Google Scholar 

  32. Wittkowsky AK, Boccuzzi SJ, Wogen J, et al.: Frequency of concurrent use of warfarin with potentially interacting drugs. Pharmacotherapy 2004, 24:1668–1674.

    Article  PubMed  CAS  Google Scholar 

  33. Brigden ML, Kay C, Le A, et al.: Audit of the frequency and clinical response to excessive oral anticoagulation in an outpatient population. Am J Hematol 1998, 59:22–27.

    Article  PubMed  CAS  Google Scholar 

  34. Murphy PT, Casey MC, Abrams K: Audit of patients on oral anticoagulants with international normalized ratios of eight or above. Clin Lab Haematol 1998, 20:253–257.

    Article  PubMed  CAS  Google Scholar 

  35. Naganuma M, Shiga T, Nishikata K, et al.: Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy. J Cardiovasc Pharmacol Ther 2001, 6:363–367.

    PubMed  CAS  Google Scholar 

  36. Sanoski CA, Bauman JL: Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long term therapy. Chest 2002, 121:19–23.

    Article  PubMed  CAS  Google Scholar 

  37. Kurnik D, Loebstein R, Farfel Z, et al.: Complex drugdrug-disease interactions between amiodarone, warfarin, and the thyroid gland. Medicine (Baltimore) 2004, 83:107–113.

    Article  Google Scholar 

  38. Visser LE, Penning van Beest FJ, Kasbergen AA, et al.: Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants. Thromb Haemost 2002, 88:705–710.

    PubMed  CAS  Google Scholar 

  39. Panneerselvam S, Baglin C, Lefort W, Baglin T: Analysis of risk factors for over anticoagulation in patients receiving long term warfarin. Br J Haematol 1998, 103:422–424.

    Article  PubMed  CAS  Google Scholar 

  40. Penning van Beest FJA, van Meegen E, Rosendaal FR, Stricker BH: Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs. Clin Pharmacol Ther 2001, 69:451–457.

    Article  Google Scholar 

  41. Andrus MR: Oral anticoagulant drug interactions with statins: case report of fluvastatin and review of the literature. Pharmacotherapy 2004, 24:285–290.

    Article  PubMed  Google Scholar 

  42. Rey AM, Gums JG: Altered absorption of digoxin, sustained-release quinidine, and warfarin with sucralfate administration. DICP 1991, 25:745–746.

    PubMed  CAS  Google Scholar 

  43. Jahnchen E, Meinertz T, Gilfrich HJ, et al.: Enhanced elimination of warfarin during treatment with cholestyramine. Br J Clin Pharmacol 1978, 5:437–440.

    PubMed  CAS  Google Scholar 

  44. Chan TY: Adverse interactions between warfarin and nonsteroidal anti-inflammatory drugs: mechanisms, clinical significance, and avoidance. Ann Pharmacother 1995, 29:1274–1283.

    PubMed  CAS  Google Scholar 

  45. Howard PA, Ellerbeck EF, Engelman KK, Patterson KL: The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation. Pharmacoepidemiol Drug Saf 2002, 11:569–576.

    Article  PubMed  CAS  Google Scholar 

  46. Shek KL, Chan LN, Nutescu E: Warfarin-acetaminophen drug interaction revisited. Pharmacotherapy 1999, 19:1153–1158.

    Article  PubMed  CAS  Google Scholar 

  47. Hylek EM, Heiman H, Skates SJ, et al.: Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998, 279:657–662.

    Article  PubMed  CAS  Google Scholar 

  48. Bell WR: Acetaminophen and warfarin: undesirable synergy. JAMA 1998, 279:702–703.

    Article  PubMed  CAS  Google Scholar 

  49. Thijssen HH, Soute BA, Vervoort LM, Claessens JG: Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle. Thromb Haemost 2004, 92:797–802.

    PubMed  CAS  Google Scholar 

  50. Fattinger K, Frisullo R, Masche U, et al.: No clinically relevant drug interaction between paracetamol and phenprocoumon based on a pharmacoepidemiological cohort study in medical inpatients. Eur J Clin Pharmacol 2002, 57:863–867.

    Article  PubMed  CAS  Google Scholar 

  51. Gadisseur AP, Van Der Meer FJ, Rosendaal FR: Sustained intake of paracetamol (acetaminophen) during oral anticoagulant therapy with coumarins does not cause clinically important INR changes: a randomized double-blind clinical trial. J Thromb Haemost 2003, 1:714–717.

    Article  PubMed  CAS  Google Scholar 

  52. Heck AM, DeWitt BA, Lukes AL: Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000, 57:1221–1227. Fairly through review of drug interactions and potential mechanism of action between various herbal and dietary supplements and warfarin.

    PubMed  CAS  Google Scholar 

  53. Kim JM, White RH: Effect of vitamin E on the anticoagulant response to warfarin. Am J Cardiol 1996, 77:545–546.

    Article  PubMed  CAS  Google Scholar 

  54. Harris JE: Interaction of dietary factors with oral anticoagulants: review and applications. J Am Diet Assoc 1995, 95:580–584.

    Article  PubMed  CAS  Google Scholar 

  55. Kurnik D, Lubetsky A, Loebstein R, et al.: Multivitamin supplements may affect warfarin anticoagulation in susceptible patients. Ann Pharmacother 2003, 37:1603–1606.

    Article  PubMed  Google Scholar 

  56. Buckley MA, Goff AD, Knapp WE: Fish oil interaction with warfarin. Ann Pharmacother 2004, 38:50–52.

    Article  PubMed  Google Scholar 

  57. Vaes LPJ, Chyka PA: Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother 2000, 34:1478–1482.

    PubMed  CAS  Google Scholar 

  58. Wittkowsky AK: Drug interactions update: drugs, herbs, and oral anticoagulation. J Thromb Thrombolysis 2001, 12:67–71.

    Article  PubMed  CAS  Google Scholar 

  59. Smith L, Ernst E, Ewings P, et al.: Co-ingestion of herbal medicines and warfarin. Br J Gen Pract 2004, 54:439–441.

    PubMed  Google Scholar 

  60. Chan TY: Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann Pharmacother 2001, 35:501–504.

    Article  PubMed  CAS  Google Scholar 

  61. Page RL, Lawrence JD: Potentiation of warfarin by dong quai. Pharmacotherapy 1999, 19:870–876.

    Article  PubMed  Google Scholar 

  62. Wong AL, Chan TY: Interaction between warfarin and the herbal product quilinggao. Ann Pharmacother 2003, 37:836–838.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Antithrombosis Service, College of Pharmacy - Pharmacy Practice, University of Illinois at Chicago, 833 South Wood Street, MC 886, Room 164, 60612, Chicago, IL, USA

    Edith A. Nutescu PharmD

Authors
  1. Edith A. Nutescu PharmD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cathy M. Helgason MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nutescu, E.A., Helgason, C.M. Concomitant drug, dietary, and lifestyle issues in patients with atrial fibrillation receiving anticoagulation therapy for stroke prophylaxis. Curr Treat Options Cardio Med 7, 241–250 (2005). https://doi.org/10.1007/s11936-005-0052-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-005-0052-9

Keywords

Search

Navigation